167 related articles for article (PubMed ID: 30060466)
1. Be Aware of Aggregators in the Search for Potential Human
Viviani LG; Piccirillo E; Cheffer A; de Rezende L; Ulrich H; Carmona-Ribeiro AM; Amaral AT
Molecules; 2018 Jul; 23(8):. PubMed ID: 30060466
[TBL] [Abstract][Full Text] [Related]
2. Virtual Screening Approach for the Identification of Hydroxamic Acids as Novel Human Ecto-5'-Nucleotidase Inhibitors.
Viviani LG; Piccirillo E; Ulrich H; Amaral AT
J Chem Inf Model; 2020 Feb; 60(2):621-630. PubMed ID: 31714079
[TBL] [Abstract][Full Text] [Related]
3. Virtual screening identifies novel sulfonamide inhibitors of ecto-5'-nucleotidase.
Ripphausen P; Freundlieb M; Brunschweiger A; Zimmermann H; Müller CE; Bajorath J
J Med Chem; 2012 Jul; 55(14):6576-81. PubMed ID: 22731815
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a soluble form of human CD73 with ecto-5'-nucleotidase activity.
Heuts DP; Weissenborn MJ; Olkhov RV; Shaw AM; Gummadova J; Levy C; Scrutton NS
Chembiochem; 2012 Nov; 13(16):2384-91. PubMed ID: 22997138
[TBL] [Abstract][Full Text] [Related]
5. 4-Aminopyridine based amide derivatives as dual inhibitors of tissue non-specific alkaline phosphatase and ecto-5'-nucleotidase with potential anticancer activity.
Hassan S; Ejaz SA; Saeed A; Shehzad M; Ullah Khan S; Lecka J; Sévigny J; Shabir G; Iqbal J
Bioorg Chem; 2018 Feb; 76():237-248. PubMed ID: 29197225
[TBL] [Abstract][Full Text] [Related]
6. Isonicotinohydrazones as inhibitors of alkaline phosphatase and ecto-5'-nucleotidase.
Channar PA; Shah SJ; Hassan S; Nisa ZU; Lecka J; Sévigny J; Bajorath J; Saeed A; Iqbal J
Chem Biol Drug Des; 2017 Mar; 89(3):365-370. PubMed ID: 27589035
[TBL] [Abstract][Full Text] [Related]
7. A domino reaction of 3-chlorochromones with aminoheterocycles. Synthesis of pyrazolopyridines and benzofuropyridines and their optical and ecto-5'-nucleotidase inhibitory effects.
Miliutina M; Janke J; Hassan S; Zaib S; Iqbal J; Lecka J; Sévigny J; Villinger A; Friedrich A; Lochbrunner S; Langer P
Org Biomol Chem; 2018 Jan; 16(5):717-732. PubMed ID: 29303198
[TBL] [Abstract][Full Text] [Related]
8. 2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.
Bhattarai S; Pippel J; Scaletti E; Idris R; Freundlieb M; Rolshoven G; Renn C; Lee SY; Abdelrahman A; Zimmermann H; El-Tayeb A; Müller CE; Sträter N
J Med Chem; 2020 Mar; 63(6):2941-2957. PubMed ID: 32045236
[TBL] [Abstract][Full Text] [Related]
9. Identification of sulfonic acids as efficient ecto-5'-nucleotidase inhibitors.
Iqbal J; Saeed A; Raza R; Matin A; Hameed A; Furtmann N; Lecka J; Sévigny J; Bajorath J
Eur J Med Chem; 2013; 70():685-91. PubMed ID: 24215819
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the human ecto-5'-nucleotidase (CD73): insights into the regulation of purinergic signaling.
Knapp K; Zebisch M; Pippel J; El-Tayeb A; Müller CE; Sträter N
Structure; 2012 Dec; 20(12):2161-73. PubMed ID: 23142347
[TBL] [Abstract][Full Text] [Related]
11. Ecto-5'-nucleotidase/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line.
Dietrich F; Figueiró F; Filippi-Chiela EC; Cappellari AR; Rockenbach L; Tremblay A; de Paula PB; Roesler R; Filho AB; Sévigny J; Morrone FB; Battastini AMO
J Cancer Res Clin Oncol; 2018 Mar; 144(3):469-482. PubMed ID: 29305710
[TBL] [Abstract][Full Text] [Related]
12. Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Seidler J; McGovern SL; Doman TN; Shoichet BK
J Med Chem; 2003 Oct; 46(21):4477-86. PubMed ID: 14521410
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of molecular model-based discovery of ecto-5'-nucleotidase inhibitors on the basis of X-ray structures.
Furtmann N; Bajorath J
Bioorg Med Chem; 2013 Nov; 21(21):6616-22. PubMed ID: 24012379
[TBL] [Abstract][Full Text] [Related]
14. Molecular Dynamics Simulations of the Human Ecto-5'-Nucleotidase (h-ecto-5'-NT, CD73): Insights into Protein Flexibility and Binding Site Dynamics.
Viviani LG; Kokh DB; Wade RC; T-do Amaral A
J Chem Inf Model; 2023 Aug; 63(15):4691-4707. PubMed ID: 37532679
[TBL] [Abstract][Full Text] [Related]
15. Sulfonylhydrazones: Design, synthesis and investigation of ectonucleotidase (ALP & e5'NT) inhibition activities.
Younus HA; Hameed A; Mahmood A; Khan MS; Saeed M; Batool F; Asari A; Mohamad H; Pelletier J; Sévigny J; Iqbal J; Al-Rashida M
Bioorg Chem; 2020 Jul; 100():103827. PubMed ID: 32402802
[TBL] [Abstract][Full Text] [Related]
16. A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.
McGovern SL; Caselli E; Grigorieff N; Shoichet BK
J Med Chem; 2002 Apr; 45(8):1712-22. PubMed ID: 11931626
[TBL] [Abstract][Full Text] [Related]
17. Development of a fast CE method for high throughput screening of ecto-5'-nucleotidase inhibitors.
Raza R; Bai Y; Liu H
Electrophoresis; 2018 Oct; 39(20):2612-2618. PubMed ID: 29775215
[TBL] [Abstract][Full Text] [Related]
18. No correlation between CD73 expression and ecto-5'-nucleotidase activity on blood mononuclear cells in vitro. Evidence of CD73 (ecto-5'-nucleotidase) on blood mononuclear cells with distinct antigenic properties.
Christensen LD
APMIS; 1996 Feb; 104(2):126-34. PubMed ID: 8619914
[TBL] [Abstract][Full Text] [Related]
19. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold.
Baqi Y; Lee SY; Iqbal J; Ripphausen P; Lehr A; Scheiff AB; Zimmermann H; Bajorath J; Müller CE
J Med Chem; 2010 Mar; 53(5):2076-86. PubMed ID: 20146483
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action.
Geoghegan JC; Diedrich G; Lu X; Rosenthal K; Sachsenmeier KF; Wu H; Dall'Acqua WF; Damschroder MM
MAbs; 2016; 8(3):454-67. PubMed ID: 26854859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
